NO. 2 KARUK TEXTS 147 'Imxa0a'kkg'em.' Xd8s 'zi1O kunp'4ip 6ka'r'. XdS purd',n kunp'mm?t?'stVS, pa'ifdppl-tttca's. Xa's kunipt&ns" . Viri 'd?ff vira kun?Ppma pamukuni krivra'am.
Notice of Sale and/or Bill of Salefor a Motor Vehicle, Mobile Home, OffHighway Vehicle or Vessel Bill of Sale (Seller and purchaser mustcomplete sections 1, 2 (when applicable) & 3) 1. Motor Vehicle,
ed Pharmaceutical Science 01 (0 9 ) ; 2 0 11 : 116 - 120 ISSN: 2231 - 3354 Received on : 0 9 - 1 1 - 2011 Revised o n : 1 5 :1 1 :201 1 Accepted on: 21 - 1 1 - 2011 Tamil Selvi A., Dinesh M. G. Chan
ITY RESERVE PROJECT DOCUMENT PREPARED BY ECOPARTNERS, LLC. Project Title Rimba Raya Biodiversity Reserve Project Version v1.8 Date of Issue 20 December 2019 Project Location Indonesia, Kalimantan (
Ohje 12824/5 Ohje 12824/5 isällysluettelo1 JOHDANTO2 LAINSÄÄDÄNTÖ2.1 Kansalliset säädökset2.2 EUsäädökset2.3 Rehuihin liittyvät määritelmät, joita käytetään tässä oppaassa3 REHUJEN
– Official Closing Meeting of IGCP 653, June 2020 A Baltic perspective on the role of the GOBE: H igh resolution stratigraphy through early Palaeozoic ecosystems chang e June 8 – 12, 2020 Copenh
Senior Vice President, Director Wealth & Family Oce 502-585-8914 YTouma@hilliard.com Rob Crady, CTFA Senior Vice President, Relationship Manager RCrady@hilliard.com Kathleen Harrison Senior Vice
List of Members of the International Hea
List of Members of the International Health Regulations ( IHR ) Review Committee on second e xtension for establishing national public health capacities and on IHR implementation CHAIR Professor Didier HOUSSIN, President of the French Agency for the Evaluation of research and higher Education, Paris, France VICE - CHAIR Dr Ximena AGUILERA , Director Center of Epidemiology and Health Policy, Faculty of Medicine , Universidad del Desarrollo , Santiago , Chile RAPPORTEUR Mr Andrew FORSYTH, Team Leader, Pu blic Health Group, Ministry of Health, Wellington, New Zealand MEMBERS Dr Idris AL - ABAIDANI , Director , Department of Communicable Disease Surveillance and Control , Directorate General of Health Affairs , Ministry of Health (HQ) , Muscat , Oman Dr Martin CETRON , Director, Division of Global Migration and Quarantine , National Center for Emerging and Zoonotic Infectious Diseases , Centers for Disease Control and Prevention , Atlanta , United States of America Mr Andrew FORSYTH , T eam Leader , Public Health Group , Ministry of Health , Wellington , New Zealand Dr Stela GHEORGHITA , Department of Epidemiology of Communicable diseases , National Centre for Public Health , Chisinau , Republic of Moldova Dr Hayat KHOGALI , Director of Epid emics and Zoonosis Departments, Federal Ministry of Health , Khartoum , Sudan Professor Abdulsalami NASIDI , Director , Nigeria Centre for Disease Control , Abuja , Nigeria Dr Kazunori OISHI , Director , Infectious Diseases Surveillance Center , National Institute of Infectious Diseases , Tokyo , Japan Mr Graham RADY , Monitoring and Evaluation Consultant , Canberra , Australia Professor Petri RUUTU , Head , Department of Infectious Disease Epidemiology National Public Health Institute , Helsinki , Finland
Professor Kuku VOYI , Professor for Environmental and Occupational Health , University of Pretoria , Pretoria , S outh Africa Dr Somsak WATTANASRI , Senior Consultant , Bureau of Epidemiology , Department of Disease Control , Ministry of Public Health , Nontaburi , Thailand DECLARATIONS OF INTERESTS Professor Petri RUUTU Professor Petri Ruutu has declared that he does consultancy work in the area of Finnish communicable diseases law development, the Global Health Security Agenda, and in the area of candidate E uropean U nion Member States` communicable diseases control assessment. He receives an income in this regard that WHO’s Declaration of Interest Policy for Experts reg ards as potentially significant (i.e. in excess of 5,000 USD ) . Professor Kuku VOYI Professor Kuku Voyi has declared that she trains WHO fellows on IHR in - country implementation at the University of Preto ria continuing education center. She receives an income in this regard that WHO’s Declaration of Interest Policy for Experts rega rds as potentially signifi cant ( i.e. in excess of 5,000 USD ) . The interests summarized above do not give rise to a conflict of interest such that the experts concerned should be partially or totally excluded from participation in the Review Committee. However, following WHO's Decl aration of Interest Policy for Experts , they were disclosed within the Committee so that other members were aware of them. All other Members of the Review Committee declared no relevant interests. A number of the Review Committee Members have extensive governmental experience and expertise – and consulting with WHO – in the areas that are the subject of the Review Committee proceedings, which were considered very relevant and important for the challenging ta sks faced by the Committee.